EZH2 and diffuse large B-cell lymphoma: However, it has recently been suggested that the H3K27 methylation profile may not be fully correlated with EZH2 mutation status in diffused large B-cell lymphoma.19, 20 Thus, some EZH2 non-mutated patients may also benefit from EZH2 inhibitor therapy.